Search research articles
Contact Us
Filters
Showing results (81-90 of 157) with videos related to
Page
of 16
Sort By:
The Journal of Infectious Diseases
|
November 26, 2015
L159F and V321A Sofosbuvir-Associated Hepatitis C Virus NS5B Substitutions
Evguenia S Svarovskaia, Edward Gane, Hadas Dvory-Sobol, et al.
JCI Insight
|
January 26, 2018
DNA methylation signatures reflect aging in patients with nonalcoholic steatohepatitis
Rohit Loomba, Yevgeniy Gindin, Zhaoshi Jiang, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
October 15, 2013
Combination of vaniprevir with peginterferon and ribavirin significantly increases the rate of SVR in treatment-experienced patients with chronic HCV genotype 1 infection and cirrhosis
Maribel Rodriguez-Torres, Albrecht Stoehr, Edward J Gane, et al.
Antiviral Therapy
|
November 16, 2022
EDP-514 in healthy subjects and nucleos(t)ide reverse transcriptase inhibitor-suppressed patients with chronic hepatitis B
Jordan J Feld, Eric Lawitz, Tuan Nguyen, et al.
The New England Journal of Medicine
|
April 1, 2011
Boceprevir for previously treated chronic HCV genotype 1 infection
Bruce R Bacon, Stuart C Gordon, Eric Lawitz, et al.
Gastroenterology
|
March 16, 2016
Efficacy of Direct-Acting Antiviral Combination for Patients With Hepatitis C Virus Genotype 1 Infection and Severe Renal Impairment or End-Stage Renal Disease
Paul J Pockros, K Rajender Reddy, Parvez S Mantry, et al.
Journal of Hepatology
|
April 22, 2015
Grazoprevir and elbasvir plus ribavirin for chronic HCV genotype-1 infection after failure of combination therapy containing a direct-acting antiviral agent
Xavier Forns, Stuart C Gordon, Eli Zuckerman, et al.
Alimentary Pharmacology & Therapeutics
|
March 2, 2022
Sofosbuvir and risk of estimated glomerular filtration rate decline or end-stage renal disease in patients with renal impairment
Mark Sulkowski, Laura E Telep, Massimo Colombo, et al.
Hepatology (Baltimore, Md.)
|
August 13, 2011
Multiple ascending dose study of BMS-790052, a nonstructural protein 5A replication complex inhibitor, in patients infected with hepatitis C virus genotype 1
Richard E Nettles, Min Gao, Marc Bifano, et al.
Journal of Hepatology
|
November 28, 2012
Sofosbuvir (GS-7977) plus peginterferon/ribavirin in treatment-naïve patients with HCV genotype 1: a randomized, 28-day, dose-ranging trial
Maribel Rodriguez-Torres, Eric Lawitz, Kris V Kowdley, et al.
Page
of 16
Search research articles
Search
Showing results (81-90 of 157) with videos related to
Sort By:
Page
of 16
The Journal of Infectious Diseases
|
November 26, 2015
L159F and V321A Sofosbuvir-Associated Hepatitis C Virus NS5B Substitutions
Evguenia S Svarovskaia, Edward Gane, Hadas Dvory-Sobol, et al.
JCI Insight
|
January 26, 2018
DNA methylation signatures reflect aging in patients with nonalcoholic steatohepatitis
Rohit Loomba, Yevgeniy Gindin, Zhaoshi Jiang, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
October 15, 2013
Combination of vaniprevir with peginterferon and ribavirin significantly increases the rate of SVR in treatment-experienced patients with chronic HCV genotype 1 infection and cirrhosis
Maribel Rodriguez-Torres, Albrecht Stoehr, Edward J Gane, et al.
Antiviral Therapy
|
November 16, 2022
EDP-514 in healthy subjects and nucleos(t)ide reverse transcriptase inhibitor-suppressed patients with chronic hepatitis B
Jordan J Feld, Eric Lawitz, Tuan Nguyen, et al.
The New England Journal of Medicine
|
April 1, 2011
Boceprevir for previously treated chronic HCV genotype 1 infection
Bruce R Bacon, Stuart C Gordon, Eric Lawitz, et al.
Gastroenterology
|
March 16, 2016
Efficacy of Direct-Acting Antiviral Combination for Patients With Hepatitis C Virus Genotype 1 Infection and Severe Renal Impairment or End-Stage Renal Disease
Paul J Pockros, K Rajender Reddy, Parvez S Mantry, et al.
Journal of Hepatology
|
April 22, 2015
Grazoprevir and elbasvir plus ribavirin for chronic HCV genotype-1 infection after failure of combination therapy containing a direct-acting antiviral agent
Xavier Forns, Stuart C Gordon, Eli Zuckerman, et al.
Alimentary Pharmacology & Therapeutics
|
March 2, 2022
Sofosbuvir and risk of estimated glomerular filtration rate decline or end-stage renal disease in patients with renal impairment
Mark Sulkowski, Laura E Telep, Massimo Colombo, et al.
Hepatology (Baltimore, Md.)
|
August 13, 2011
Multiple ascending dose study of BMS-790052, a nonstructural protein 5A replication complex inhibitor, in patients infected with hepatitis C virus genotype 1
Richard E Nettles, Min Gao, Marc Bifano, et al.
Journal of Hepatology
|
November 28, 2012
Sofosbuvir (GS-7977) plus peginterferon/ribavirin in treatment-naïve patients with HCV genotype 1: a randomized, 28-day, dose-ranging trial
Maribel Rodriguez-Torres, Eric Lawitz, Kris V Kowdley, et al.
Page
of 16